News Releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
March 16, 2020- Top-Line Data from Phase 2 EMPhASIS Trial in Relapsing-Remitting Multiple Sclerosis Expected in Third Quarter 2020 -
-
January 8, 2020Phase 1 Clinical Studies to begin in First Half of 2020
-
December 4, 2019IMU-856 has the potential to address one of the putative root causes of inflammatory bowel disease without impairing the immune system
-
October 10, 2019- Milestone Achieved Nine Months Ahead of Initial Schedule; Top-Line Data Expected in Q3 2020 -